The US Food and Drug Administration (FDA) has finalized its guidance on dose banding to assist sponsors in labeling ready-to-use containers for injectable drug products. With this guidance, FDA aims ...
Stakeholders want more discussions on the kinds of data that can be used when stakeholders consider using model-informed drug development (MIDD) approaches. They note that there is uncertainty about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results